SCHEMBL31640565

SCHEMBL31640565

Nc1ncnc2c1c(-c1noc(C3CC3)c1B(O)O)nn2C1CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 7/20 0.53
▸ SRC P12931 12/20 0.46
▸ KDR P35968 12/20 0.46
▸ LCK P06239 2/20 0.46
▸ CDC7 O00311 1/20 0.46
▸ PLK4 O00444 1/20 0.46
▸ DYRK3 O43781 1/20 0.46
▸ JAK2 O60674 1/20 0.46
▸ PRKD3 O94806 1/20 0.46
▸ MAP4K4 O95819 1/20 0.46
▸ NTRK1 P04629 1/20 0.46
▸ INSR P06213 1/20 0.46
▸ FYN P06241 1/20 0.46
▸ CDK1 P06493 1/20 0.46
▸ ROS1 P08922 1/20 0.46
▸ FER P16591 1/20 0.46
▸ PRKACA P17612 1/20 0.46
▸ RPS6KB1 P23443 1/20 0.46
▸ CDK2 P24941 1/20 0.46
▸ MARK3 P27448 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31639606 0.85 SRC (0.47) RETSRCKDRLCKPLK4
SCHEMBL31640083 0.84 RET (0.57) RETSRCKDRLCKCDC7
SCHEMBL31639823 0.83 RET (0.60) RETSRCKDRRPS6KB1FLT4
SCHEMBL31639492 0.82 RET (0.40) RETKDRRPS6KB1FLT4HCK
SCHEMBL31639668 0.82 RET (0.44) RETKDRRPS6KB1FLT4HCK
SCHEMBL31639633 0.80 RET (0.41) RETKDRRPS6KB1FLT4HCK
SCHEMBL31639265 0.80 RET (0.62) RETSRCKDRRPS6KB1FLT4
SCHEMBL31640064 0.80 RET (0.62) RETSRCKDRLCKPIK3CD
SCHEMBL31639663 0.74 RET (0.59) RETSRCKDRLCKEGFR
SCHEMBL31639920 0.74 RET (0.73) RETSRCKDRLCKRPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137605-A1 COMPOUNDS FOR TARGETED DEGRADATION OF PROTO-ONCOGENE TYROSINE PROTEIN KINASE RECEPTOR C4 THERAPEUTICS, INC. (US) 2025-06-26 — — WO disclosed
Send feedback